Electroacupuncture for poststroke spasticity (EAPSS): protocol for a randomised controlled trial

Cai, Y, Zhang, C, Ouyang, W, Li, J, Nong, W, Zhang, T, Xue, C and Wen, Z 2018, 'Electroacupuncture for poststroke spasticity (EAPSS): protocol for a randomised controlled trial', BMJ Open, vol. 8, no. 2, pp. 1-9.


Document type: Journal Article
Collection: Journal Articles

Attached Files
Name Description MIMEType Size
n2006082466.pdf Published Version application/pdf 973.18KB
Title Electroacupuncture for poststroke spasticity (EAPSS): protocol for a randomised controlled trial
Author(s) Cai, Y
Zhang, C
Ouyang, W
Li, J
Nong, W
Zhang, T
Xue, C
Wen, Z
Year 2018
Journal name BMJ Open
Volume number 8
Issue number 2
Start page 1
End page 9
Total pages 9
Publisher BMJ Group
Abstract Introduction Spasticity is a common complication of stroke. Current therapies for poststroke spasticity (PSS) have been reported to be associated with high costs, lack of long-term benefit and unwanted adverse events (AEs). Electroacupuncture (EA) has been used for PSS, however, its efficacy and safety is yet to be confirmed by high-quality clinical studies. This study is designed to evaluate the add-on effects and safety profile of EA when used in combination with usual care (UC). Methods and analysis This study is a parallel group randomised controlled trial. A total of 136 participants will be included and randomly assigned to either the treatment group (EA plus UC) or the control group (UC alone). Prior to the main trial, a pilot study involving 30 participants will be conducted to assess the feasibility of the trial protocol. EA will be administered by registered acupuncturists for 20min to 30 min, three times per week for 4 weeks. The primary outcome measure (Modified Ashworth Scale) and secondary outcome measures (Fugl-Meyer Assessment and Barthel Index) will be evaluated at baseline, the end of treatment (week 4) and the end of follow-up (week 8). AEs will be monitored, recorded and reported, and their causality will be explored. Ethics and dissemination Ethics approval was obtained from the ethics committees of Guangdong Provincial Hospital of Chinese Medicine and RMIT University in December 2016. The results will be disseminated in a peer-reviewed journal, and PhD theses and might be presented at international conferences.
Subject Medical Biochemistry: Lipids
DOI - identifier 10.1136/bmjopen-2017-017912
Copyright notice This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/
ISSN 2044-6055
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 17 Abstract Views, 18 File Downloads  -  Detailed Statistics
Created: Thu, 06 Dec 2018, 10:39:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us